The effect of the extract from Anthocyanin oligomer (grape skin extract) administration in dry eye patients (Double blind placebo control study)

Dong-A University0 sites108 target enrollmentTBD

Overview

No summary available.

Registry

who.int

Start Date

TBD

End Date

September 30, 2018

Last Updated

4 years ago

Study Type

Interventional Study

Sex

All

Sponsor

•? Over the age of 18 healthy adult.
•? Feeling of irritation, pain, itching, if appealing vision and symptoms such as glare.
•? Hyperaemia conjunctivae, cornea erosion (nei with scale), meibomian gland and irregularities on the eye surface If you don't seem organic or more of the opinion.
•? Schirmer's test award if more than 500 mm has drawbacks.
•? If (tear break up time) 10 seconds or less destruction nunmulmak.
•? Contact lens wearers must stop wearing them for the past month to select them.

•? If the patient is unable to test due to mental retardation or other reasons,
•? A patient who is judged by the medical staff to be unable to participate in the study due to other ophthalmic diseases.
•? If you do not want to or cannot observe the progress of visiting a research institute as part of treatment.
•? Patients who do not want to participate in the study.
•? In the case of diseases that can confuse the risk or outcome of surgery, such as immunosuppression and connective tissue disease,
•? A woman of childbearing age.
•? Other than eye trauma, infection, and dry eye surface inflammatory diseases, and those with a history of eye surgery within the last 6 months are excluded.
•? If you have a history of using ophthalmic cyclosporin, steroid preparations, and other dryness treatment drugs within the last 1 month,
•? Those who take antihypertensive drugs such as antihistamine and beta blockers, diuretics, antidepressants (especially tricyclic antidepressants, Parkinson's treatment drugs, etc.) that can worsen dry eye cannot participate in this study.
•? Excluding subjects with diseases that can worsen dry eye by increasing inflammation of the surface of the eye, such as Sjogren syndrome, rheumatoid arthritis, ankylosing spondylitis, and erythema lupus.